Rubius Therapeutics
Cambridge, US · Founded 2013 · Delaware corporation · 2 known investors
Biotech
Founders & leadership
TS
Torben Straight NissenExecutive
JP
Joanne ProtanoExecutive
DE
David EpsteinNamed on SEC filing
HF
Harvey F. LodishNamed on SEC filing
MR
Michael RosenblattNamed on SEC filing
RP
Roger PomerantzNamed on SEC filing
RS
Board
NB
PB
Peter Barton HuttBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$216.2M disclosed across 2 rounds · 2017–2018
▶$101.2MraisedMar 2018 · 27 investors · BiotechnologyRule 506(b)
▶$101.2MraisedMar 2018 · 27 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Christopher L. CarpenterExecutive Officer
- Torben Straight NissenExecutive Officer, Director
- Robert S. LangerDirector
- Noubar B. AfeyanDirector
- Francis CussDirector
- Catherine SohnDirector
- Michael RosenblattDirector
- Roger PomerantzDirector
- Joanne ProtanoExecutive Officer
- David EpsteinDirector
- Andrew OhExecutive Officer
- Offering amount
- $101.2M
- Amount sold
- $101.2M
- First sale
- Feb 2018
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$115MraisedJun 2017 · 16 investors · BiotechnologyRule 506(b)
▶$115MraisedJun 2017 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Peter Barton HuttDirector
- David EpsteinDirector
- Harvey F. LodishDirector
- Michael RosenblattDirector
- Roger PomerantzDirector
- Robert S. LangerDirector
- Noubar B. AfeyanDirector
- Torben Straight NissenExecutive Officer, Director
- Joanne ProtanoExecutive Officer
- Offering amount
- $120M
- Amount sold
- $115M
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through Rubius Therapeutics went on to found or lead other companies.
Frequently asked questions
- Who are Rubius Therapeutics's investors?
- Rubius Therapeutics's investors include Flagship Pioneering, Kendall Capital Partners.
- How much funding has Rubius Therapeutics raised?
- Rubius Therapeutics has disclosed $216.2M raised across 2 rounds.
- Where is Rubius Therapeutics headquartered?
- Rubius Therapeutics is headquartered in Cambridge, US.